Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer.
Takashima Y, Komatsu S, Ohashi T, Kiuchi J, Nishibeppu K, Kamiya H, Arakawa H, Ishida R, Shimizu H, Arita T, Konishi H, Shiozaki A, Kubota T, Fujiwara H, Otsuji E.
Takashima Y, et al. Among authors: fujiwara h.
Cancer Sci. 2023 Jul;114(7):3027-3040. doi: 10.1111/cas.15830. Epub 2023 May 15.
Cancer Sci. 2023.
PMID: 37190912
Free PMC article.